deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT02619162

Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics

Nintedanib Plus Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Phase 0/1 Safety and Pharmacodynamics

Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III

Conditions Breast Cancer
Interventions Letrozole Nintedanib
Updated 8 times since 2017 Last updated: Jul 22, 2019 Started: Jul 31, 2015 Primary completion: Nov 30, 2017 Completion: Jun 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Breast Cancer and is currently completed. Centro Nacional de Investigaciones Oncologicas CARLOS III leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotRecruiting~Jan 2019 – ~Aug 2019 · 7 months · monthly snapshotUnknown Status~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Aug 2019 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Unknown Status → Completed

  5. Jan 2019 — Aug 2019 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  2. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  3. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE1

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centro Nacional de Investigaciones Oncologicas CARLOS III
  • Dr, Ramón Colomer i Bosch
  • Dr. Miguel Angel Quintela Fandiño (CNIO)
  • FUNDACIÓN CRIS (Marta Cardona) as promotor
Data source: Centro Nacional de Investigaciones Oncologicas CARLOS III

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations